Epsolay Cream
Product Images NDC 51862-772

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Epsolay (NDC 51862-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Epsolay 01)

Chemical structure diagram depicting the molecular composition of Benzoyl Peroxide, the active ingredient in Epsolay topical cream.*

FDA Label Image

Figure 1 (Epsolay 02)

A line graph comparing the IGA Success Rate (%) over a 12-week period between Epsolay (Benzoyl Peroxide 30 mg/g cream) and a vehicle cream. The x-axis represents weeks (Baseline, 4, 8, 12), and the y-axis shows the percentage success rate. The Epsolay line shows a steady increase in success rate, reaching close to 50% by week 12, while the vehicle cream shows a much lower success rate, plateauing around 20%.*

FDA Label Image

Figure 2 (Epsolay 03)

A line graph comparing the Investigator Global Assessment (IGA) success rate (%) over 12 weeks between Epsolay cream and vehicle cream. The graph shows higher success rates for Epsolay, increasing steadily from baseline to 50% at week 12, while vehicle cream reaches about 30% success rate by week 12.*

FDA Label Image

Figure 3 (Epsolay 04)

Line graph showing mean change in inflammatory lesions over 12 weeks comparing Epsolay cream 30 mg/g with vehicle cream. The graph plots weeks on the x-axis and mean change in inflammatory lesions on the y-axis, indicating an increase for both treatments with Epsolay showing a higher mean change at each time point.*

FDA Label Image

Figure 4 (Epsolay 05)

A line graph comparing mean change in inflammatory lesions over 12 weeks between Epsolay cream and a vehicle cream. The graph shows weeks on the x-axis and mean change in inflammatory lesions on the y-axis, with Epsolay demonstrating a greater increase in change compared to the vehicle cream over time.*

FDA Label Image

Principal Display Panel (30 g Bottle Carton)

Packaging label for Epsolay (benzoyl peroxide) cream 5%, a topical prescription drug in a 30g pump. The label includes dosage form, strength, NDC 51862-772-30, and distributor Mayne Pharma Commercial LLC. Instructions caution against ophthalmic, oral, or intravaginal use, note non-child-resistant packaging, and provide storage and usage details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.